Atlas Trials

Efficacy, Safety, Tolerability of AXA1125 in Fatigue After COVID-19 Infection

Clinical trial NCT05152849 · COMPLETED

Trial details

NCT number
NCT05152849
Sponsor
Axcella Health, Inc
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection
Start date
2021-12-15
Primary completion
2022-06-21
Enrollment
41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.